Global Vaccines For Children (VFC) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 96

Published Date: 03 Mar 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Vaccines For Children (VFC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Vaccines For Children (VFC) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Vaccines For Children (VFC) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Vaccines For Children (VFC) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Recombinant Vaccines
    Viral Vaccines
    Polysaccharide Vaccines
    Others

Market segment by Application can be divided into
    Government Institution
    Private Sector
    Other

The key market players for global Vaccines For Children (VFC) market are listed below:
    GSK
    Sanofi
    Merck
    Pfizer
    Jintan
    CSL
    MedImmune LLC
    J&J(Crucell)
    China National Biotec
    Tiantan
    Hualan
    Kangtai
    Hissen

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Vaccines For Children (VFC) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccines For Children (VFC), with price, sales, revenue and global market share of Vaccines For Children (VFC) from 2019 to 2021.
Chapter 3, the Vaccines For Children (VFC) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccines For Children (VFC) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vaccines For Children (VFC) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Vaccines For Children (VFC) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Vaccines For Children (VFC) Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Vaccines For Children (VFC) Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Recombinant Vaccines
        1.2.3 Viral Vaccines
        1.2.4 Polysaccharide Vaccines
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Vaccines For Children (VFC) Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Government Institution
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Global Vaccines For Children (VFC) Market Size & Forecast
        1.4.1 Global Vaccines For Children (VFC) Sales in Value (2016-2026))
        1.4.2 Global Vaccines For Children (VFC) Sales in Volume (2016-2026)
        1.4.3 Global Vaccines For Children (VFC) Price by Type (2016-2026) & (US$/Dose)
    1.5 Global Vaccines For Children (VFC) Production Capacity Analysis
        1.5.1 Global Vaccines For Children (VFC) Total Production Capacity (2016-2026)
        1.5.2 Global Vaccines For Children (VFC) Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Vaccines For Children (VFC) Market Drivers
        1.6.2 Vaccines For Children (VFC) Market Restraints
        1.6.3 Vaccines For Children (VFC) Trends Analysis

2 Manufacturers Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Vaccines For Children (VFC) Product and Services
        2.1.4 GSK Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Sanofi
        2.2.1 Sanofi Details
        2.2.2 Sanofi Major Business
        2.2.3 Sanofi Vaccines For Children (VFC) Product and Services
        2.2.4 Sanofi Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Merck
        2.3.1 Merck Details
        2.3.2 Merck Major Business
        2.3.3 Merck Vaccines For Children (VFC) Product and Services
        2.3.4 Merck Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Vaccines For Children (VFC) Product and Services
        2.4.4 Pfizer Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Jintan
        2.5.1 Jintan Details
        2.5.2 Jintan Major Business
        2.5.3 Jintan Vaccines For Children (VFC) Product and Services
        2.5.4 Jintan Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 CSL
        2.6.1 CSL Details
        2.6.2 CSL Major Business
        2.6.3 CSL Vaccines For Children (VFC) Product and Services
        2.6.4 CSL Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 MedImmune LLC
        2.7.1 MedImmune LLC Details
        2.7.2 MedImmune LLC Major Business
        2.7.3 MedImmune LLC Vaccines For Children (VFC) Product and Services
        2.7.4 MedImmune LLC Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 J&J(Crucell)
        2.8.1 J&J(Crucell) Details
        2.8.2 J&J(Crucell) Major Business
        2.8.3 J&J(Crucell) Vaccines For Children (VFC) Product and Services
        2.8.4 J&J(Crucell) Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 China National Biotec
        2.9.1 China National Biotec Details
        2.9.2 China National Biotec Major Business
        2.9.3 China National Biotec Vaccines For Children (VFC) Product and Services
        2.9.4 China National Biotec Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Tiantan
        2.10.1 Tiantan Details
        2.10.2 Tiantan Major Business
        2.10.3 Tiantan Vaccines For Children (VFC) Product and Services
        2.10.4 Tiantan Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Hualan
        2.11.1 Hualan Details
        2.11.2 Hualan Major Business
        2.11.3 Hualan Vaccines For Children (VFC) Product and Services
        2.11.4 Hualan Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Kangtai
        2.12.1 Kangtai Details
        2.12.2 Kangtai Major Business
        2.12.3 Kangtai Vaccines For Children (VFC) Product and Services
        2.12.4 Kangtai Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Hissen
        2.13.1 Hissen Details
        2.13.2 Hissen Major Business
        2.13.3 Hissen Vaccines For Children (VFC) Product and Services
        2.13.4 Hissen Vaccines For Children (VFC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Vaccines For Children (VFC) Sales by Manufacturer
    3.1 Global Vaccines For Children (VFC) Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Vaccines For Children (VFC) Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Vaccines For Children (VFC)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Vaccines For Children (VFC) Manufacturer Market Share
        3.4.2 Top 6 Vaccines For Children (VFC) Manufacturer Market Share
    3.5 Global Vaccines For Children (VFC) Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Vaccines For Children (VFC) Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Vaccines For Children (VFC) Market Size by Region
        4.1.1 Global Vaccines For Children (VFC) Sales in Volume by Region (2016-2026)
        4.1.2 Global Vaccines For Children (VFC) Revenue by Region (2016-2026)
    4.2 North America Vaccines For Children (VFC) Revenue (2016-2026)
    4.3 Europe Vaccines For Children (VFC) Revenue (2016-2026)
    4.4 Asia-Pacific Vaccines For Children (VFC) Revenue (2016-2026)
    4.5 South America Vaccines For Children (VFC) Revenue (2016-2026)
    4.6 Middle East and Africa Vaccines For Children (VFC) Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Vaccines For Children (VFC) Sales in Volume by Type (2016-2026)
    5.2 Global Vaccines For Children (VFC) Revenue by Type (2016-2026)
    5.3 Global Vaccines For Children (VFC) Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Vaccines For Children (VFC) Sales in Volume by Application (2016-2026)
    6.2 Global Vaccines For Children (VFC) Revenue by Application (2016-2026)
    6.3 Global Vaccines For Children (VFC) Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Vaccines For Children (VFC) Sales by Type (2016-2026)
    7.2 North America Vaccines For Children (VFC) Sales by Application (2016-2026)
    7.3 North America Vaccines For Children (VFC) Market Size by Country
        7.3.1 North America Vaccines For Children (VFC) Sales in Volume by Country (2016-2026)
        7.3.2 North America Vaccines For Children (VFC) Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Vaccines For Children (VFC) Sales by Type (2016-2026)
    8.2 Europe Vaccines For Children (VFC) Sales by Application (2016-2026)
    8.3 Europe Vaccines For Children (VFC) Market Size by Country
        8.3.1 Europe Vaccines For Children (VFC) Sales in Volume by Country (2016-2026)
        8.3.2 Europe Vaccines For Children (VFC) Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Vaccines For Children (VFC) Sales by Type (2016-2026)
    9.2 Asia-Pacific Vaccines For Children (VFC) Sales by Application (2016-2026)
    9.3 Asia-Pacific Vaccines For Children (VFC) Market Size by Region
        9.3.1 Asia-Pacific Vaccines For Children (VFC) Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Vaccines For Children (VFC) Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Vaccines For Children (VFC) Sales by Type (2016-2026)
    10.2 South America Vaccines For Children (VFC) Sales by Application (2016-2026)
    10.3 South America Vaccines For Children (VFC) Market Size by Country
        10.3.1 South America Vaccines For Children (VFC) Sales in Volume by Country (2016-2026)
        10.3.2 South America Vaccines For Children (VFC) Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Vaccines For Children (VFC) Sales by Type (2016-2026)
    11.2 Middle East & Africa Vaccines For Children (VFC) Sales by Application (2016-2026)
    11.3 Middle East & Africa Vaccines For Children (VFC) Market Size by Country
        11.3.1 Middle East & Africa Vaccines For Children (VFC) Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Vaccines For Children (VFC) Typical Distributors
    12.3 Vaccines For Children (VFC) Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Vaccines For Children (VFC) Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Vaccines For Children (VFC) Revenue by Application, (USD Million), 2021-2026
    Table 3. GSK Basic Information, Manufacturing Base and Competitors
    Table 4. GSK Major Business
    Table 5. GSK Vaccines For Children (VFC) Product and Services
    Table 6. GSK Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 8. Sanofi Major Business
    Table 9. Sanofi Vaccines For Children (VFC) Product and Services
    Table 10. Sanofi Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Merck Basic Information, Manufacturing Base and Competitors
    Table 12. Merck Major Business
    Table 13. Merck Vaccines For Children (VFC) Product and Services
    Table 14. Merck Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 16. Pfizer Major Business
    Table 17. Pfizer Vaccines For Children (VFC) Product and Services
    Table 18. Pfizer Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Jintan Basic Information, Manufacturing Base and Competitors
    Table 20. Jintan Major Business
    Table 21. Jintan Vaccines For Children (VFC) Product and Services
    Table 22. Jintan Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. CSL Basic Information, Manufacturing Base and Competitors
    Table 24. CSL Major Business
    Table 25. CSL Vaccines For Children (VFC) Product and Services
    Table 26. CSL Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. MedImmune LLC Basic Information, Manufacturing Base and Competitors
    Table 28. MedImmune LLC Major Business
    Table 29. MedImmune LLC Vaccines For Children (VFC) Product and Services
    Table 30. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. J&J(Crucell) Basic Information, Manufacturing Base and Competitors
    Table 32. J&J(Crucell) Major Business
    Table 33. J&J(Crucell) Vaccines For Children (VFC) Product and Services
    Table 34. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. China National Biotec Basic Information, Manufacturing Base and Competitors
    Table 36. China National Biotec Major Business
    Table 37. China National Biotec Vaccines For Children (VFC) Product and Services
    Table 38. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Tiantan Basic Information, Manufacturing Base and Competitors
    Table 40. Tiantan Major Business
    Table 41. Tiantan Vaccines For Children (VFC) Product and Services
    Table 42. Tiantan Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Hualan Basic Information, Manufacturing Base and Competitors
    Table 44. Hualan Major Business
    Table 45. Hualan Vaccines For Children (VFC) Product and Services
    Table 46. Hualan Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Kangtai Basic Information, Manufacturing Base and Competitors
    Table 48. Kangtai Major Business
    Table 49. Kangtai Vaccines For Children (VFC) Product and Services
    Table 50. Kangtai Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. Hissen Basic Information, Manufacturing Base and Competitors
    Table 52. Hissen Major Business
    Table 53. Hissen Vaccines For Children (VFC) Product and Services
    Table 54. Hissen Vaccines For Children (VFC) Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 55. Global Vaccines For Children (VFC) Sales by Manufacturer (2019-2021e) & (K Doses)
    Table 56. Global Vaccines For Children (VFC) Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 57. Market Position of Manufacturers in Vaccines For Children (VFC), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 58. Global Vaccines For Children (VFC) Production Capacity by Company, (K Doses): 2020 VS 2021
    Table 59. Head Office and Vaccines For Children (VFC) Production Site of Key Manufacturer
    Table 60. Vaccines For Children (VFC) New Entrant and Capacity Expansion Plans
    Table 61. Vaccines For Children (VFC) Mergers & Acquisitions in the Past Five Years
    Table 62. Global Vaccines For Children (VFC) Sales by Region (2016-2021e) & (K Doses)
    Table 63. Global Vaccines For Children (VFC) Sales by Region (2021-2026) & (K Doses)
    Table 64. Global Vaccines For Children (VFC) Revenue by Region (2016-2021e) & (USD Million)
    Table 65. Global Vaccines For Children (VFC) Revenue by Region (2021-2026) & (USD Million)
    Table 66. Global Vaccines For Children (VFC) Sales by Type (2016-2021e) & (K Doses)
    Table 67. Global Vaccines For Children (VFC) Sales by Type (2021-2026) & (K Doses)
    Table 68. Global Vaccines For Children (VFC) Revenue by Type (2016-2021e) & (USD Million)
    Table 69. Global Vaccines For Children (VFC) Revenue by Type (2021-2026) & (USD Million)
    Table 70. Global Vaccines For Children (VFC) Price by Type (2016-2021e) & (US$/Dose)
    Table 71. Global Vaccines For Children (VFC) Price by Type (2021-2026) & (US$/Dose)
    Table 72. Global Vaccines For Children (VFC) Sales by Application (2016-2021e) & (K Doses)
    Table 73. Global Vaccines For Children (VFC) Sales by Application (2021-2026) & (K Doses)
    Table 74. Global Vaccines For Children (VFC) Revenue by Application (2016-2021e) & (USD Million)
    Table 75. Global Vaccines For Children (VFC) Revenue by Application (2021-2026) & (USD Million)
    Table 76. Global Vaccines For Children (VFC) Price by Application (2016-2021e) & (US$/Dose)
    Table 77. Global Vaccines For Children (VFC) Price by Application (2021-2026) & (US$/Dose)
    Table 78. North America Vaccines For Children (VFC) Sales by Country (2016-2021e) & (K Doses)
    Table 79. North America Vaccines For Children (VFC) Sales by Country (2021-2026) & (K Doses)
    Table 80. North America Vaccines For Children (VFC) Revenue by Country (2016-2021e) & (USD Million)
    Table 81. North America Vaccines For Children (VFC) Revenue by Country (2021-2026) & (USD Million)
    Table 82. North America Vaccines For Children (VFC) Sales by Type (2016-2021e) & (K Doses)
    Table 83. North America Vaccines For Children (VFC) Sales by Type (2021-2026) & (K Doses)
    Table 84. North America Vaccines For Children (VFC) Sales by Application (2016-2021e) & (K Doses)
    Table 85. North America Vaccines For Children (VFC) Sales by Application (2021-2026) & (K Doses)
    Table 86. Europe Vaccines For Children (VFC) Sales by Country (2016-2021e) & (K Doses)
    Table 87. Europe Vaccines For Children (VFC) Sales by Country (2021-2026) & (K Doses)
    Table 88. Europe Vaccines For Children (VFC) Revenue by Country (2016-2021e) & (USD Million)
    Table 89. Europe Vaccines For Children (VFC) Revenue by Country (2021-2026) & (USD Million)
    Table 90. Europe Vaccines For Children (VFC) Sales by Type (2016-2021e) & (K Doses)
    Table 91. Europe Vaccines For Children (VFC) Sales by Type (2021-2026) & (K Doses)
    Table 92. Europe Vaccines For Children (VFC) Sales by Application (2016-2021e) & (K Doses)
    Table 93. Europe Vaccines For Children (VFC) Sales by Application (2021-2026) & (K Doses)
    Table 94. Asia-Pacific Vaccines For Children (VFC) Sales by Region (2016-2021e) & (K Doses)
    Table 95. Asia-Pacific Vaccines For Children (VFC) Sales by Region (2021-2026) & (K Doses)
    Table 96. Asia-Pacific Vaccines For Children (VFC) Revenue by Region (2016-2021e) & (USD Million)
    Table 97. Asia-Pacific Vaccines For Children (VFC) Revenue by Region (2021-2026) & (USD Million)
    Table 98. Asia-Pacific Vaccines For Children (VFC) Sales by Type (2016-2021e) & (K Doses)
    Table 99. Asia-Pacific Vaccines For Children (VFC) Sales by Type (2021-2026) & (K Doses)
    Table 100. Asia-Pacific Vaccines For Children (VFC) Sales by Application (2016-2021e) & (K Doses)
    Table 101. Asia-Pacific Vaccines For Children (VFC) Sales by Application (2021-2026) & (K Doses)
    Table 102. South America Vaccines For Children (VFC) Sales by Country (2016-2021e) & (K Doses)
    Table 103. South America Vaccines For Children (VFC) Sales by Country (2021-2026) & (K Doses)
    Table 104. South America Vaccines For Children (VFC) Revenue by Country (2016-2021e) & (USD Million)
    Table 105. South America Vaccines For Children (VFC) Revenue by Country (2021-2026) & (USD Million)
    Table 106. South America Vaccines For Children (VFC) Sales by Type (2016-2021e) & (K Doses)
    Table 107. South America Vaccines For Children (VFC) Sales by Type (2021-2026) & (K Doses)
    Table 108. South America Vaccines For Children (VFC) Sales by Application (2016-2021e) & (K Doses)
    Table 109. South America Vaccines For Children (VFC) Sales by Application (2021-2026) & (K Doses)
    Table 110. Middle East & Africa Vaccines For Children (VFC) Sales by Country (2016-2021e) & (K Doses)
    Table 111. Middle East & Africa Vaccines For Children (VFC) Sales by Country (2021-2026) & (K Doses)
    Table 112. Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2016-2021e) & (USD Million)
    Table 113. Middle East & Africa Vaccines For Children (VFC) Revenue by Country (2021-2026) & (USD Million)
    Table 114. Middle East & Africa Vaccines For Children (VFC) Sales by Type (2016-2021e) & (K Doses)
    Table 115. Middle East & Africa Vaccines For Children (VFC) Sales by Type (2021-2026) & (K Doses)
    Table 116. Middle East & Africa Vaccines For Children (VFC) Sales by Application (2016-2021e) & (K Doses)
    Table 117. Middle East & Africa Vaccines For Children (VFC) Sales by Application (2021-2026) & (K Doses)
    Table 118. Direct Channel Pros & Cons
    Table 119. Indirect Channel Pros & Cons
    Table 120. Vaccines For Children (VFC) Typical Distributors
    Table 121. Vaccines For Children (VFC) Typical Customers
List of Figures
    Figure 1. Vaccines For Children (VFC) Picture
    Figure 2. Global Vaccines For Children (VFC) Sales Market Share by Type in 2020
    Figure 3. Recombinant Vaccines
    Figure 4. Viral Vaccines
    Figure 5. Polysaccharide Vaccines
    Figure 6. Others
    Figure 7. Global Vaccines For Children (VFC) Sales Market Share by Application in 2020
    Figure 8. Government Institution
    Figure 9. Private Sector
    Figure 10. Other
    Figure 11. Global Vaccines For Children (VFC) Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
    Figure 12. Global Vaccines For Children (VFC) Market Size and Forecast (2016-2026) & (USD Million)
    Figure 13. Global Vaccines For Children (VFC) Sales (2016-2026) & (K Doses)
    Figure 14. Global Vaccines For Children (VFC) Price by Type (2016-2026) & (US$/Dose)
    Figure 15. Global Vaccines For Children (VFC) Production Capacity (2016-2026) & (K Doses)
    Figure 16. Global Vaccines For Children (VFC) Production Capacity by Geographic Region: 2020 VS 2021
    Figure 17. Vaccines For Children (VFC) Market Drivers
    Figure 18. Vaccines For Children (VFC) Market Restraints
    Figure 19. Vaccines For Children (VFC) Market Trends
    Figure 20. Global Vaccines For Children (VFC) Sales Market Share by Manufacturer in 2020
    Figure 21. Global Vaccines For Children (VFC) Revenue Market Share by Manufacturer in 2020
    Figure 22. Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 23. Top 3 Vaccines For Children (VFC) Manufacturer (Revenue) Market Share in 2020
    Figure 24. Top 6 Vaccines For Children (VFC) Manufacturer (Revenue) Market Share in 2020
    Figure 25. Global Vaccines For Children (VFC) Sales Market Share by Region (2016-2026)
    Figure 26. Global Vaccines For Children (VFC) Revenue Market Share by Region (2016-2026)
    Figure 27. North America Vaccines For Children (VFC) Revenue (2016-2026) & (USD Million)
    Figure 28. Europe Vaccines For Children (VFC) Revenue (2016-2026) & (USD Million)
    Figure 29. Asia-Pacific Vaccines For Children (VFC) Revenue (2016-2026) & (USD Million)
    Figure 30. South America Vaccines For Children (VFC) Revenue (2016-2026) & (USD Million)
    Figure 31. Middle East & Africa Vaccines For Children (VFC) Revenue (2016-2026) & (USD Million)
    Figure 32. Global Vaccines For Children (VFC) Sales Market Share by Type (2016-2026)
    Figure 33. Global Vaccines For Children (VFC) Revenue Market Share by Type (2016-2026)
    Figure 34. Global Vaccines For Children (VFC) Price by Type (2016-2026) & (US$/Dose)
    Figure 35. Global Vaccines For Children (VFC) Sales Market Share by Application (2016-2026)
    Figure 36. Global Vaccines For Children (VFC) Revenue Market Share by Application (2016-2026)
    Figure 37. Global Vaccines For Children (VFC) Price by Application (2016-2026) & (US$/Dose)
    Figure 38. North America Vaccines For Children (VFC) Sales Market Share by Type (2016-2026)
    Figure 39. North America Vaccines For Children (VFC) Sales Market Share by Application (2016-2026)
    Figure 40. North America Vaccines For Children (VFC) Sales Market Share by Country (2016-2026)
    Figure 41. North America Vaccines For Children (VFC) Revenue Market Share by Country (2016-2026)
    Figure 42. United States Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Canada Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Mexico Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Europe Vaccines For Children (VFC) Sales Market Share by Type (2016-2026)
    Figure 46. Europe Vaccines For Children (VFC) Sales Market Share by Application (2016-2026)
    Figure 47. Europe Vaccines For Children (VFC) Sales Market Share by Country (2016-2026)
    Figure 48. Europe Vaccines For Children (VFC) Revenue Market Share by Country (2016-2026)
    Figure 49. Germany Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. France Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. United Kingdom Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Russia Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Italy Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Asia-Pacific Vaccines For Children (VFC) Sales Market Share by Region (2016-2026)
    Figure 55. Asia-Pacific Vaccines For Children (VFC) Sales Market Share by Application (2016-2026)
    Figure 56. Asia-Pacific Vaccines For Children (VFC) Sales Market Share by Region (2016-2026)
    Figure 57. Asia-Pacific Vaccines For Children (VFC) Revenue Market Share by Region (2016-2026)
    Figure 58. China Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Japan Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Korea Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. India Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Southeast Asia Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Australia Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South America Vaccines For Children (VFC) Sales Market Share by Type (2016-2026)
    Figure 65. South America Vaccines For Children (VFC) Sales Market Share by Application (2016-2026)
    Figure 66. South America Vaccines For Children (VFC) Sales Market Share by Country (2016-2026)
    Figure 67. South America Vaccines For Children (VFC) Revenue Market Share by Country (2016-2026)
    Figure 68. Brazil Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Argentina Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Type (2016-2026)
    Figure 71. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Application (2016-2026)
    Figure 72. Middle East & Africa Vaccines For Children (VFC) Sales Market Share by Country (2016-2026)
    Figure 73. Middle East & Africa Vaccines For Children (VFC) Revenue Market Share by Country (2016-2026)
    Figure 74. Turkey Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Egypt Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Saudi Arabia Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. South Africa Vaccines For Children (VFC) Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Sales Channel: Direct Channel vs Indirect Channel
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen

Related Reports

Global Vaccines For Children (VFC) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Vaccines For Children (VFC) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 13 Jan 2022

date Pharma & Healthcare

The Vaccines For Children (VFC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

vaccines for children vfc

Vaccines For Children (VFC)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>